Home > Healthcare > Medical Devices > Diagnostic Devices > biological imaging reagents market
Get a free sample of Biological Imaging Reagents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Biological Imaging Reagents Market
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
The biological imaging reagents industry is characterized by the presence of several established and emerging players that offer a variety of products across the globe. The market players compete based on factors such as product quality, innovation, regulatory compliance, customer service, and pricing strategies.
Prominent players operating in the biological imaging reagents industry include:
The market size of biological imaging reagents reached USD 12.2 billion in 2023 and is set to register 7.3% CAGR between 2024 and 2032, due to increasing prevalence of chronic conditions and substantial investments in R&D.
The clinical diagnostics segment is projected to reach USD 9.7 billion by 2032, driven by the need for enhancing the accuracy, sensitivity, and specificity of various imaging modalities.
North America market accounted for USD 4.7 billion in in 2023, led by advanced healthcare infrastructure and significant R&D investments.
Bayer AG, Bracco, Carl Zeiss, Cell Signaling Technology, Danaher, General Electric Company, Guerbet, Jubilant Pharmova Limited, Luminex Corporation, and Nikon Corporation, among others.